Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Wang, Mei  [Clear All Filters]
Journal Article
Zhu H, Zhang L, Wu Y, Dong B, Guo W, Wang M, Yang L, Fan X, Tang Y, Liu N, et al. T-ALL leukemia stem cell 'stemness' is epigenetically controlled by the master regulator SPI1. Elife. 2018;7.
Wang Y, Wang H, Zhang Y, Du Z, Si W, Fan S, Qin D, Wang M, Duan Y, Li L, et al. Reprogramming of Meiotic Chromatin Architecture during Spermatogenesis. Mol Cell. 2019;73(3):547-561.e6.
Tate EW, Soday L, de la Lastra ALosada, Wang M, Lin H. Protein lipidation in cancer: mechanisms, dysregulation and emerging drug targets. Nat Rev Cancer. 2024.
Yin X, Hu L, Zhang Y, Zhu C, Cheng H, Xie X, Shi M, Zhu P, Zhao X, Chen W, et al. PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient mice. Bone Marrow Transplant. 2019.
Gao S, Mao F, Zhang B, Zhang L, Zhang X, Wang M, Yan Y, Yang T, Zhang J, Zhu W, et al. Mouse bone marrow-derived mesenchymal stem cells induce macrophage M2 polarization through the nuclear factor-κB and signal transducer and activator of transcription 3 pathways. Exp Biol Med (Maywood). 2014.
Xu X-J, Gao S, Wang M, Qian H, Gu G-Y, Zhang K, Xu W-R. Methylation status of the FHIT gene in the transformed human mesenchymal F6 stem cell line. Oncol Lett. 2015;9(6):2661-2666.
Sun WTian, Xiang W, Ng BLing, Asari K, Bunte RM, Casey PJ, Wang M, Chuah C. Inhibition of isoprenylcysteine carboxylmethyltransferase augments BCR-ABL1 tyrosine kinase inhibition-induced apoptosis in chronic myeloid leukaemia. Exp Hematol. 2015.
Lau HYeung, Ramanujulu PM, Guo D, Yang T, Wirawan M, Casey PJ, Go M-L, Wang M. An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo. Cancer Biol Ther. 2014;15(9).
Jiang T, Wang M, Zhang N, Dong Q, Tang X. Identification and protection of early cardiotoxicity in acute myeloid leukemia patients undergoing transplantation. Hematology. 2023;28(1):2239569.
Peng X, Xu H, Zhou Y, Wang B, Yan Y, Zhang X, Wang M, Gao S, Zhu W, Xu W, et al. Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury. Exp Biol Med (Maywood). 2013;238(8):960-70.
Zhang B, Wang M, Gong A, Zhang X, Wu X, Zhu Y, Shi H, Wu L, Zhu W, Qian H, et al. HucMSC-exosome mediated -Wnt4 signaling is required for cutaneous wound healing. Stem Cells. 2014.
Wang L, Wu C, Xu J, Gong Z, Cao X, Huang J, Dong H, Zhu W, Huang F, Zhou C, et al. GC‑MSC‑derived circ_0024107 promotes gastric cancer cell lymphatic metastasis via fatty acid oxidation metabolic reprogramming mediated by the miR‑5572/6855‑5p/CPT1A axis. Oncol Rep. 2023;50(1).
Cui L, Liu T, Huang C, Yang F, Luo L, Sun L, Zhao Y, Wang D, Wang M, Ji Y, et al. Gastric Cancer Mesenchymal Stem Cells Trigger Endothelial Cell Functional Changes to Promote Cancer Progression. Stem Cell Rev Rep. 2024.
Gao Q, Huang C, Liu T, Yang F, Chen Z, Sun L, Zhao Y, Wang M, Luo L, Zhou C, et al. Gastric cancer mesenchymal stem cells promote tumor glycolysis and chemoresistance by regulating B7H3 in gastric cancer cells. J Cell Biochem. 2024.
Wang Q, Huang C, Wang D, Tao Z, Zhang H, Zhao Y, Wang M, Zhou C, Xu J, Shen B, et al. Gastric cancer derived mesenchymal stem cells promoted DNA repair and cisplatin resistance through up-regulating PD-L1/Rad51 in gastric cancer. Cell Signal. 2023:110639.
Huang J, Wang X, Wen J, Zhao X, Wu C, Wang L, Cao X, Dong H, Xu X, Huang F, et al. Gastric cancer cell-originated small extracellular vesicle induces metabolic reprogramming of BM-MSCs through ERK-PPARγ-CPT1A signaling to potentiate lymphatic metastasis. Cancer Cell Int. 2023;23(1):87.
Zhu WLong, Tong H, Teh JTsong, Wang M. Forkhead Box Protein O3 Transcription Factor Negatively Regulates Autophagy in Human Cancer Cells by Inhibiting Forkhead Box Protein O1 Expression and Cytosolic Accumulation. PLoS One. 2014;9(12):e115087.
Gu H, Ji R, Zhang X, Wang M, Zhu W, Qian H, Chen Y, Jiang P, Xu W. Exosomes derived from human mesenchymal stem cells promote gastric cancer cell growth and migration via the activation of the Akt pathway. Mol Med Rep. 2016.
Ji R, Zhang B, Zhang X, Xue J, Yuan X, Yan Y, Wang M, Zhu W, Qian H, Xu W. Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer. Cell Cycle. 2015.
Wang M, Zhang J, Dou Y, Liang M, Xie Y, Xue P, Liu L, Li C, Wang Y, Tao F, et al. Design, Synthesis, and Biological Evaluation of Novel Thioureidobenzamide (TBA) Derivatives as HBV Capsid Assembly Modulators. J Med Chem. 2023.
Shen J, Huang C, Cui L, Zhao Y, Zhu M, Chen Z, Wang M, Zhu W, Shen B. Chemotherapeutic Drugs Endow Gastric Cancer Mesenchymal Stem Cells with Stronger Tumor-Promoting Ability. J Environ Pathol Toxicol Oncol. 2024;43(1):1-13.
Yan F-H, Wang M, Huang Y, Jiang E-L, Ma Q-L, Wei J-L, Pang A-M, Zhang R-L, Feng S-Z, Han M-Z. [Analyses of risk factors for intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2013;34(12):1020-3.